Pfizer and Moderna Stocks: Down 30% and 27% – Buy and Hold by Terry Bingman 06.04.2024 Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...
BioVaxys Acquires IMV’s Immunotherapy Tech for Growth by John Darbie 13.02.2024 BioVaxys Technology Corp. finalizes agreement to acquire IMV Inc.'s immunotherapy technology portfolio, expanding its cancer vaccine portfolio and positioning itself ...